Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Long Term Debt 2017–2025
Aquestive Therapeutics Inc. annual/quarterly long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Aquestive Therapeutics Inc. long term debt for the quarter ending December 31, 2025 were 45.0M, a 0.00% increase year-over-year.
- Aquestive Therapeutics Inc. long term debt for 2025 were 45.0M, a 0.00% increase from 2024.
- Aquestive Therapeutics Inc. long term debt for 2024 were 45.0M, a 0.00% increase from 2023.
- Aquestive Therapeutics Inc. long term debt for 2023 were 45.0M, a 12.62% decrease from 2020.
- Aquestive Therapeutics Inc. long term debt for 2020 were 51.5M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aquestive Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $45 |
| 2024 | $45 |
| 2023 | $45 |
| 2020 | $52 |
| 2019 | $70 |
| Aquestive Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $45 |
| 2024-12-31 | $45 |
| 2023-12-31 | $45 |
| 2020-12-31 | $52 |
| 2019-12-31 | $70 |
Aquestive Therapeutics Inc. Long Term Debt — FAQ
Aquestive Therapeutics Inc. (AQST) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's long term debt history?
The chart and table above show Aquestive Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.